Reduction of nitric oxide release from alveolar macrophages by a lipocortin peptide
Nitric oxide (NO), produced by alveolar macrophages (AM) is used as a marker of respiratory tract inflammation. Lipocortin 1 (Lc-1) is an anti-inflammatory, glucocorticoid-inducible protein. The current aims were to determine whether (a) an Lc-1-derived peptide, Ac2-26, inhibited lipopolysaccharide...
Saved in:
Main Authors: | A. M. Kamal, T. D. Tetley, I. R. Witherden, S. F. Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1998-01-01
|
Series: | Mediators of Inflammation |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09629359891234 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential Modulation of Annexin I Binding Sites on Monocytes and Neutrophils
by: H. S. Euzger, et al.
Published: (1999-01-01) -
Evaluation of Inflammatory Cytokine Secretion by Human Alveolar Macrophages
by: J. E. Losa García, et al.
Published: (1999-01-01) -
Plasma-derived extracellular vesicles prime alveolar macrophages for autophagy and ferroptosis in sepsis-induced acute lung injury
by: Rongzong Ye, et al.
Published: (2025-02-01) -
Dentin-derived alveolar bone graft for alveolar augmentation: A systematic review
by: Dedy Agoes Mahendra, et al.
Published: (2024-07-01) -
The opposite effect of convulsant drugs on neuronal and endothelial nitric oxide synthase – A possible explanation for the dual proconvulsive/anticonvulsive action of nitric oxide
by: Vega Rasgado Lourdes A., et al.
Published: (2023-03-01)